Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ILMN Illumina Inc
- Stocks
- Healthcare
- NASDAQ: ILMN
Price (delayed)
$78.21
Market cap
$12.38B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.05
Enterprise value
$13.8B
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a
Highlights
Illumina's EPS has increased by 26% YoY and by 21% QoQ
ILMN's net income is up by 25% year-on-year and by 21% since the previous quarter
The equity has plunged by 59% YoY
Illumina's debt has increased by 15% YoY
Key stats
What are the main financial stats of ILMN
Market
Valuations
Earnings
Shares outstanding
158.3M
Market cap
$12.38B
Enterprise value
$13.8B
Price to earnings (P/E)
N/A
Price to book (P/B)
5.23
Price to sales (P/S)
2.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.18
Revenue
$4.34B
Gross profit
$2.88B
Operating income
-$557M
Net income
-$965M
EBIT
-$781M
EBITDA
-$466M
Free cash flow
$869M
Per share
Balance sheet
Liquidity
EPS
-$6.05
EPS diluted
-$6.07
Free cash flow per share
$5.47
Book value per share
$14.95
Revenue per share
$27.28
TBVPS
$30.13
Total assets
$6.18B
Total liabilities
$3.81B
Debt
$2.53B
Equity
$2.37B
Working capital
$1.23B
Debt to equity
1.07
Current ratio
1.86
Quick ratio
1.34
Net debt/EBITDA
-3.04
Margins
Efficiency
Dividend
EBITDA margin
-10.7%
Gross margin
66.3%
Net margin
-22.3%
Operating margin
-12.8%
Return on assets
-15.7%
Return on equity
-46.5%
Return on invested capital
-16.2%
Return on capital employed
-16.5%
Return on sales
-18%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ILMN stock price
How has the Illumina stock price performed over time
Intraday
-2.6%
1 week
2.44%
1 month
4.2%
1 year
-32.33%
YTD
-41.47%
QTD
-1.42%
Financial performance
How have Illumina's revenue and profit performed over time
Revenue
$4.34B
Gross profit
$2.88B
Operating income
-$557M
Net income
-$965M
Gross margin
66.3%
Net margin
-22.3%
The operating income has soared by 50% YoY and by 33% from the previous quarter
Illumina's operating margin has increased by 49% YoY and by 33% from the previous quarter
ILMN's net income is up by 25% year-on-year and by 21% since the previous quarter
Illumina's net margin has increased by 22% YoY and by 20% QoQ
Price vs fundamentals
How does ILMN's price correlate with its fundamentals
Growth
What is Illumina's growth rate over time
Valuation
What is Illumina stock price valuation
P/E
N/A
P/B
5.23
P/S
2.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.18
Illumina's EPS has increased by 26% YoY and by 21% QoQ
The equity has plunged by 59% YoY
The price to book (P/B) is 41% lower than the last 4 quarters average of 8.9 and 26% lower than the 5-year quarterly average of 7.1
ILMN's P/S is 69% below its 5-year quarterly average of 9.2 and 30% below its last 4 quarters average of 4.1
Illumina's revenue has decreased by 3.5% YoY
Efficiency
How efficient is Illumina business performance
The ROE has plunged by 116% YoY and by 11% from the previous quarter
ILMN's return on invested capital is up by 35% year-on-year and by 30% since the previous quarter
The company's return on assets fell by 28% YoY but it rose by 9% QoQ
Illumina's return on sales has increased by 27% QoQ and by 25% YoY
Dividends
What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ILMN.
Financial health
How did Illumina financials performed over time
The total assets is 62% more than the total liabilities
The total assets has contracted by 38% YoY
The quick ratio has grown by 14% YoY and by 6% from the previous quarter
Illumina's debt is 7% higher than its equity
The debt to equity has soared by 182% year-on-year
The equity has plunged by 59% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.